Guess which ASX All Ords stock just leapt 9% on big US news

Investors are piling into this ASX All Ords stock on Tuesday. But why?

| More on:
Shot of a young scientist using a digital tablet while working in a lab.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The All Ordinaries Index (ASX: XAO) is up 0.7% in morning trade with one ASX All Ords stock racing ahead of those gains.

The outperforming stock in question is Avita Medical Inc (ASX: AVH).

Shares in the regenerative medicine company closed yesterday trading for $2.70. In morning trade on Tuesday, shares just leapt to $2.94 apiece, up 8.9%. After some likely profit-taking, shares are changing hands for $2.88 each at the time of writing, up 6.7%.

That leaves shares in the ASX All Ords stock down 31% in 2025.

Here's what's grabbing investor attention today.

ASX All Ords stock surges on US agreements

The Avita Medical share price is charging higher today after the company announced it has entered into a new contract manufacturing agreement with Stedical Scientific, a United States-based company, for its PermeaDerm transparent biosynthetic wound matrix.

PermeaDerm is cleared by the US Food and Drug Administration (FDA) for use in the treatment of a variety of wound types until healing is achieved.

The ASX All Ords stock also inked an amendment to its existing exclusive distribution agreement with Stedical Scientific.

Avita said the agreements will further strengthen the strategic relationship between the two companies to expand the reach and availability of PermeaDerm.

Under the new contract manufacturing agreement, which came into effect overnight, Avita Medial will manufacture PermeaDerm at Stedical Scientific's manufacturing facility in Ventura, California.

Avita Medical said it will make use of its existing infrastructure to drive the ongoing commercialisation of PermeaDerm in the US. The new agreement will also help streamline production, increase scale, and optimise manufacturing cost efficiencies to drive greater value.

The amended distribution agreement extends the contract term and modifies the revenue-sharing terms. Under the new terms, the ASX All Ords stock will retain 60% of the average sales price from PermeaDerm sales. Under the previous agreement, Avita Medical retained 50% of the average sales price.

What did management say?

Commenting on the new agreements helping to lift the ASX All Ords stock today, Avita Medical CEO Jim Corbett said:

These strategic agreements reflect our shared commitment to driving innovation and expanding market access, while ensuring that patients continue to receive first-in-class care. We look forward to leveraging our expertise to continue to drive innovation and growth in therapeutic acute wound care.

Lin Sun, chairman of Stedical Scientific, added:

PermeaDerm has demonstrated great healing results when used for various wounds. We are excited to expand our collaboration with Avita Medical through this manufacturing agreement.

This partnership ensures a robust supply chain for PermeaDerm and strengthens our commitment to delivering cutting-edge solutions to the global market.

The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Avita Medical. The Motley Fool Australia has recommended Avita Medical. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Happy young woman saving money in a piggy bank.
Share Gainers

3 ASX shares that would already have more than doubled your money in 2025

An investment in any of these ASX shares on 2 January would have more than doubled your money by now.

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a great end to the week's trading today...

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Liontown, Newmont, Paladin Energy, and ResMed shares are charging higher today

These shares are ending the week on a positive note.

Read more »

Man on computer looking at graphs
Share Gainers

Here are the top 10 ASX 200 shares today

Investors were back to the races this hump day...

Read more »

Rising share price chart.
Share Gainers

Why Orthocell, Paladin Energy, Telix, and Woodside shares are racing higher today

These shares are having a stronger day than most. But why?

Read more »

Man with rocket wings which have flames coming out of them.
Share Gainers

Why is this ASX 200 uranium stock rocketing 17% on Wednesday?

The ASX 200 uranium stock is racing higher today. But why?

Read more »

Person pretends to types on laptop drawn in sand.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a wild return for ASX shares this Tuesday.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why DroneShield, Kingsgate, Santana, and Star shares are pushing higher today

These shares are having a strong start to the week. But why?

Read more »